Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|January 31, 2002
From molecular changes to customised therapyA HemminkiCellular and Molecular Life Sciences : CMLS|June 24, 1999
The molecular basis and clinical aspects of Peutz-Jeghers syndromeA HemminkiOncoimmunology|April 9, 2016
A century of oncolysis evolves into oncolytic immunotherapyO Hemminki, A HemminkiJournal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 29, 2009
Cancer gene therapy with oncolytic adenovirusesK Guse, A HemminkiChemico-Biological Interactions|October 1, 1994
Reaction kinetics of alkyl epoxides with DNA and other nucleophilesA Hemminki, T Väyrynen, K HemminkiInternational Journal of Cancer|June 26, 2012
Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primariesK Hemminki, M Bevier, J Sundquist, et al.European Journal of Cancer (Oxford, England : 1990)|March 23, 2013
Time trends in survival from cancer of unknown primary: small steps forwardM Riihimäki, A Hemminki, K Sundquist, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2011
Survival in cancer of unknown primary site: population-based analysis by site and histologyK Hemminki, M Bevier, A Hemminki, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2012
Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries?K Hemminki, M Bevier, J Sundquist, et al.Acta Crystallographica. Section D, Biological Crystallography|February 10, 2000
X-ray studies of recombinant anti-testosterone Fab fragments: the use of PEG 3350 in crystallizationJ Valjakka, A Hemminki, T Teerinen, et al.Pageof 7